Shivang R Desai, Devinder S Dhindsa, Yi-An Ko, Pratik B Sandesara, Anurag Mehta, Chang Liu, Ayman S Tahhan, Salim S Hayek, Kiran Ejaz, Ananya Hooda, Ayman Alkhoder, Shabatun J Islam, Steven C Rogers, Agim Beshiri, Gillian Murtagh, Jonathan H Kim, Peter Wilson, Zakaria Almuwaqqat, Laurence S Sperling, Arshed A Quyyumi
Despite guideline-based therapy, patients with coronary artery disease (CAD) are at widely variable risk for cardiovascular events. This variability demands a more individualized risk assessment. Herein, we evaluate the prognostic value of 6 biomarkers: high-sensitivity C-reactive protein, heat shock protein-70, fibrin degradation products, soluble urokinase plasminogen activator receptor, high-sensitivity troponin I, and B-type natriuretic peptide. We then develop a multi-biomarker-based cardiovascular event prediction model for patients with stable CAD...
September 15, 2023: American Journal of Cardiology